Aura Biosciences, Inc.
AURA
$5.36
-$0.04-0.74%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -25.83M | -21.04M | -20.34M | -19.71M | -22.13M |
| Total Depreciation and Amortization | 291.00K | 313.00K | 313.00K | 306.00K | 324.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.53M | 2.08M | 2.17M | 1.75M | 2.39M |
| Change in Net Operating Assets | -942.00K | 3.38M | 1.73M | -6.80M | 2.03M |
| Cash from Operations | -23.95M | -15.27M | -16.13M | -24.45M | -17.39M |
| Capital Expenditure | -299.00K | -341.00K | -525.00K | -88.00K | -317.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 29.99M | 10.23M | 20.37M | 9.48M | -89.80M |
| Cash from Investing | 29.70M | 9.89M | 19.84M | 9.40M | -90.12M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 543.00K | 716.00K | 83.00K | 253.00K | 92.99M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 543.00K | 716.00K | 83.00K | 253.00K | 92.99M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 6.29M | -4.67M | 3.80M | -14.80M | -14.52M |